re: marsbar Hey numbskull.
Recurring revenue some way off yes, but don't discount milestone payments due from Medtronic. I have a suspicion that cleverly when negotiations started over a year ago, XBL and Med merged the two technical teams so that if/when negotiations were completed they were already off to a running start on collaboration. So development is already basically a year ahead, and at each stage of development progress, XBL will get lumps of cash.
Not sure of background of ACU, but I like the look of it at the moment...
XBL
xceed biotechnology ltd
